If you are or know someone who is a cardiology patient who has used or has been recommended to use an Outpatient Cardiac Telemetry (“OCT”) services device, you may have been improperly denied insurance coverage by a health insurer for the cost of the OCT device. For example, CIGNA treated OCT devices as Covered Services from 2007 through 2011, but in 2012 changed its policies and determined that OCT devices were “experimental, investigational or unproven” despite the fact that OCT devices had been prescribed for hundreds of thousands of patients for more than ten years to diagnose or rule out suspected clinically significant arrhythmias which pose a risk of stroke or heart disease. As a result, patients shouldered the financial responsibility for the use of OCT devices.
You or someone you know may have suffered financial damage because of the health insurer’s improper conduct. We will assess your claim and entitlement to pursue legal process to recover damages for the improper denial of insurance coverage with respect to the prescription and use of OCT devices as part of cardiac function assessment and diagnosis.